Ketamine pill may revolutionize treatment for hard-to-treat depression
HQ Team October 25, 2024: A recent study indicates that a new slow-release ketamine pill could offer a promising alternative for individuals suffering.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team October 25, 2024: A recent study indicates that a new slow-release ketamine pill could offer a promising alternative for individuals suffering.
Bharti Jayshankar October 24, 2024: A recent study from New York University (NYU) Grossman School of Medicine has sparked renewed interest in the.
Bharti Jayshankar October 24, 2024: In a Finnish population-based cohort study, researchers have found that mothers with a history of eating disorders or.
Modifi Biosciences, Inc., a Yale University spinout company formed in 2021, has been acquired by Merck & Co. for about $1.3 billion to.
Samsung Biologics has announced a $1.24 billion manufacturing deal with an unnamed Asian pharmaceutical company.
HQ Team October 23, 2024: Rising global temperatures have led to more frequent and severe wildfires in vulnerable ecosystems like those found in.
Alzheimer's disease has an initial silent and slow phase before the second stage of a destructive accumulation of plaques, tangles and other symptoms.
The US Food and Drug Administration has greenlighted Pfizer Inc.’s respiratory syncytial virus vaccine (RSV) Abrysvo for treating lower respiratory tract disease in.
HQ Team October 22, 2024: A new handheld device can isolate biomarkers for different diseases using sound waves from a single drop of.
HQ Team October 22, 2024: Hearing aids have emerged as a potentially significant factor in delaying the onset and progression of Parkinson’s disease.